Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Pain Res ; 17: 827-835, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38449798

RESUMO

Objective: To examine the immediate effects of a comprehensive pain course on medical students' pre-existing perceptions and attitudes toward pain patients and opioid management. Methods: First-year medical students at a major academic medical center enrolled in a required pre-clerkship pain course in June 2020 and completed pre- and post-course online surveys with Likert-scale questions about their attitudes toward pain management and opioid-related issues. Additionally, the surveys included a free-text question where the students listed the first five words that came to mind when hearing the word "opioids". These words were categorized as "professional" or "lay" words and further as having "positive", "negative", or "neutral" connotations. Data analyses included descriptive statistics, as well as non-parametric and parametric tests. Results: Fifty-four of the 119 students responded to pretest and posttest surveys and were included in paired analyses. There was a significant difference between the number of professional words used before (M=1.21, SD=0.97) and after the course (M=2.40 SD=1.33); t(52)=-6.39, P<0.001. Students also used more lay-positive words after the course (M=0.81, SD=0.63) than they used pre-course (M=0.23, SD=0.43); t(51)=-5.98, P<0.001. Students' post-course responses to several key Likert-scale questions showed significant shifts toward more positive attitudes about caring for patients with pain. For example, students acknowledged greater comfort in providing opioids for chronic pain (P<0.001) where appropriate, and enhanced interest in handling complex pain cases (P<0.001). Conclusion: Results showed that a comprehensive, multi-disciplinary pain course could greatly enhance first-year medical students' attitudes toward pain management, chronic pain patients, and the complex issues surrounding opioids.

2.
Sci Rep ; 9(1): 12681, 2019 09 03.
Artigo em Inglês | MEDLINE | ID: mdl-31481666

RESUMO

Sex disparities modulate cardiac function, although the proteins and mechanisms remain to be elucidated. We recently demonstrated a mosaic pattern of protein expression in the heart for over 100 proteins. Here we investigate one of these proteins, myosin light chain 4 (MYL4), which is important for contractile functions by increasing force production. We assayed the expression pattern of MYL4 across 756 ventricular myocardial samples from 668 individuals utilizing a semi-automated Cell Profiler method on five tissue microarrays (TMAs) of cardiac tissues across a diverse set of diseases. The percentage of MYL4 positive cells was significantly higher in male subjects independently across all five TMAs, regardless of disease state (p = 8.66e-15). Higher MYL4 expression was also modestly associated with hypertrophic cardiomyopathy (p = 6.3e-04). MYL4 expression did not associate with sudden cardiac death or other cardiomyopathies. This study demonstrates a new mosaic pattern of protein expression that underlies sex disparities in the human heart.


Assuntos
Miocárdio/metabolismo , Cadeias Leves de Miosina/metabolismo , Adulto , Idoso , Cardiomiopatia Hipertrófica/metabolismo , Cardiomiopatia Hipertrófica/patologia , Doença da Artéria Coronariana/metabolismo , Doença da Artéria Coronariana/patologia , Morte Súbita Cardíaca/patologia , Feminino , Ventrículos do Coração/citologia , Ventrículos do Coração/metabolismo , Humanos , Modelos Lineares , Masculino , Pessoa de Meia-Idade , Miocárdio/patologia , Cadeias Leves de Miosina/genética , Fatores Sexuais , Análise Serial de Tecidos
3.
Cardiovasc Pathol ; 34: 50-57, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29677652

RESUMO

Skeletal myocytes have well-established fast and slow twitch fibers with unique gene and protein specific expression patterns. By immunohistochemical staining, these show a mosaic pattern across myocytes. We hypothesized cardiac myocytes may behave similarly where some proteins are differentially expressed between mature cardiomyocytes. We utilized the tool HPASubC on over 52,000 cardiac images of the Human Protein Atlas to identify differential protein expression patterns by immunohistochemistry across the cardiomyocytes. We matched identified proteins to open chromatin and gene expression data. We identified 143 putative proteins with mosaic patterns of expression across the cardiomyocytes. We validated four of these proteins (MYL3, MYL4, PAM, and MYOM1) and demonstrated unique atrial or ventricular patterns of expression for each. Acetylation of histone H3K27 at the promoters of these four genes were consistent with the atrial/ventricular expression patterns. Despite the generally accepted homogeneity of cardiomyocytes, a small subset of proteins varies between cardiomyocytes in a mosaic pattern. This fundamental process has been previously uncharacterized. These changes may inform on different functional and disease-related activities of proteins in individual cardiomyocytes.


Assuntos
Proteínas Musculares/análise , Miócitos Cardíacos/química , Acetilação , Amidina-Liases/análise , Conectina/análise , Regulação da Expressão Gênica , Histonas/química , Humanos , Processamento de Imagem Assistida por Computador , Imuno-Histoquímica , Oxigenases de Função Mista/análise , Mosaicismo , Proteínas Musculares/genética , Cadeias Leves de Miosina/análise , Reconhecimento Automatizado de Padrão , Fenótipo , Regiões Promotoras Genéticas , Mapas de Interação de Proteínas , Proteômica/métodos
4.
Bioorg Med Chem Lett ; 28(10): 1958-1963, 2018 06 01.
Artigo em Inglês | MEDLINE | ID: mdl-29653895

RESUMO

Hypothalamic CAMKK2 represents a potential mechanism for chemically affecting satiety and promoting weight loss in clinically obese patients. Single-digit nanomolar inhibitors of CAMKK2 were identified in three related ATP-competitive series. Limited optimization of kinase selectivity, solubility, and pharmacokinetic properties were undertaken on all three series, as SAR was often transferrable. Ultimately, a 2,4-diaryl 7-azaindole was optimized to afford a tool molecule that potently inhibits AMPK phosphorylation in a hypothalamus-derived cell line, is orally bioavailable, and crosses the blood-brain barrier. When dosed orally in rodents, compound 4 t limited ghrelin-induced food intake.


Assuntos
Quinase da Proteína Quinase Dependente de Cálcio-Calmodulina/antagonistas & inibidores , Inibidores de Proteínas Quinases/química , Administração Oral , Animais , Encéfalo/metabolismo , Quinase da Proteína Quinase Dependente de Cálcio-Calmodulina/genética , Quinase da Proteína Quinase Dependente de Cálcio-Calmodulina/metabolismo , Ingestão de Alimentos/efeitos dos fármacos , Grelina/farmacologia , Ligação de Hidrogênio , Indóis/química , Indóis/metabolismo , Concentração Inibidora 50 , Camundongos , Mutagênese , Inibidores de Proteínas Quinases/metabolismo
5.
Curr Opin Gastroenterol ; 34(2): 59-70, 2018 03.
Artigo em Inglês | MEDLINE | ID: mdl-29266008

RESUMO

PURPOSE OF REVIEW: The establishment of mouse models of gallstones, and the contribution of mouse models to genetic studies of gallstone disease, as well as the latest advances in the pathophysiology of gallstones from mouse experiments are summarized. RECENT FINDINGS: The combined uses of genomic strategies and phenotypic studies in mice have successfully led to the identification of many Lith genes, which pave the way for the discovery of human LITH genes. The physical-chemical, genetic, and molecular biological studies of gallstone disease in mice with knockout or transgene of specific target genes have provided many novel insights into the complex pathophysiological mechanisms of this very common hepatobiliary disease worldwide, showing that interactions of five primary defects play a critical role in the pathogenesis of cholesterol gallstones. Based on mouse studies, a new concept has been proposed that hepatic hypersecretion of biliary cholesterol is induced by multiple Lith genes, with insulin resistance as part of the metabolic syndrome interacting with cholelithogenic environmental factors to cause the phenotype. SUMMARY: The mouse model of gallstones is crucial for elucidating the physical-chemical and genetic mechanisms of cholesterol crystallization and gallstone formation, which greatly increase our understanding of the pathogenesis of this disease in humans.


Assuntos
Subfamília G de Transportadores de Cassetes de Ligação de ATP/genética , Colelitíase/genética , Modelos Animais de Doenças , Cálculos Biliares/genética , Animais , Colelitíase/fisiopatologia , Cálculos Biliares/fisiopatologia , Predisposição Genética para Doença/genética , Humanos , Camundongos
6.
J Lipid Res ; 56(9): 1691-700, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-26152119

RESUMO

To distinguish the lithogenic effect of the classical estrogen receptor α (ERα) from that of the G protein-coupled receptor 30 (GPR30), a new estrogen receptor, on estrogen-induced gallstones, we investigated the entire spectrum of cholesterol crystallization pathways and sequences during the early stage of gallstone formation in gallbladder bile of ovariectomized female wild-type, GPR30((-/-)), ERα((-/-)), and GPR30((-/-))/ERα((-/-)) mice treated with 17ß-estradiol (E2) at 6 µg/day and fed a lithogenic diet for 12 days. E2 disrupted biliary cholesterol and bile salt metabolism through ERα and GPR30, leading to supersaturated bile and predisposing to the precipitation of cholesterol monohydrate crystals. In GPR30((-/-)) mice, arc-like and tubular crystals formed first, followed by classical parallelogram-shaped cholesterol monohydrate crystals. In ERα((-/-)) mice, precipitation of lamellar liquid crystals, typified by birefringent multilamellar vesicles, appeared earlier than cholesterol monohydrate crystals. Both crystallization pathways were accelerated in wild-type mice with the activation of GPR30 and ERα by E2. However, cholesterol crystallization was drastically retarded in GPR30((-/-))/ERα((-/-)) mice. We concluded that E2 activates GPR30 and ERα to produce liquid crystalline versus anhydrous crystalline metastable intermediates evolving to cholesterol monohydrate crystals from supersaturated bile. GPR30 produces a synergistic lithogenic action with ERα to enhance E2-induced gallstone formation.


Assuntos
Colesterol/metabolismo , Receptor alfa de Estrogênio/genética , Cálculos Biliares/metabolismo , Receptores de Estrogênio/genética , Receptores Acoplados a Proteínas G/genética , Animais , Ácidos e Sais Biliares/metabolismo , Colesterol/genética , Cristalização , Estradiol/administração & dosagem , Receptor alfa de Estrogênio/metabolismo , Estrogênios/administração & dosagem , Estrogênios/metabolismo , Feminino , Cálculos Biliares/genética , Cálculos Biliares/patologia , Humanos , Camundongos , Camundongos Knockout , Receptores de Estrogênio/metabolismo , Receptores Acoplados a Proteínas G/metabolismo
7.
Ann Hepatol ; 13(6): 728-45, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25332259

RESUMO

Epidemiological and clinical studies have found that gallstone prevalence is twice as high in women as in men at all ages in every population studied. Hormonal changes occurring during pregnancy put women at higher risk. The incidence rates of biliary sludge (a precursor to gallstones) and gallstones are up to 30 and 12%, respectively, during pregnancy and postpartum, and 1-3% of pregnant women undergo cholecystectomy due to clinical symptoms or complications within the first year postpartum. Increased estrogen levels during pregnancy induce significant metabolic changes in the hepatobiliary system, including the formation of cholesterol-supersaturated bile and sluggish gallbladder motility, two factors enhancing cholelithogenesis. The therapeutic approaches are conservative during pregnancy because of the controversial frequency of biliary disorders. In the majority of pregnant women, biliary sludge and gallstones tend to dissolve spontaneously after parturition. In some situations, however, the conditions persist and require costly therapeutic interventions. When necessary, invasive procedures such as laparoscopic cholecystectomy are relatively well tolerated, preferably during the second trimester of pregnancy or postpartum. Although laparoscopic operation is recommended for its safety, the use of drugs such as ursodeoxycholic acid (UDCA) and the novel lipid-lowering compound, ezetimibe would also be considered. In this paper, we systematically review the incidence and natural history of pregnancy-related biliary sludge and gallstone formation and carefully discuss the molecular mechanisms underlying the lithogenic effect of estrogen on gallstone formation during pregnancy. We also summarize recent progress in the necessary strategies recommended for the prevention and the treatment of gallstones in pregnant women.


Assuntos
Bile/metabolismo , Colelitíase/metabolismo , Colesterol/metabolismo , Estrogênios/metabolismo , Complicações na Gravidez/metabolismo , Anticolesterolemiantes/uso terapêutico , Azetidinas/uso terapêutico , Colagogos e Coleréticos/uso terapêutico , Colecistectomia Laparoscópica , Colelitíase/prevenção & controle , Colelitíase/terapia , Ezetimiba , Feminino , Humanos , Gravidez , Complicações na Gravidez/prevenção & controle , Complicações na Gravidez/terapia , Ácido Ursodesoxicólico/uso terapêutico
8.
Eur J Clin Invest ; 43(11): 1203-23, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-24102389

RESUMO

BACKGROUND: Dietary fat is one of the most important energy sources of all the nutrients. Fatty acids, stored as triacylglycerols (also called triglycerides) in the body, are an important reservoir of stored energy and derived primarily from animal fats and vegetable oils. DESIGN: Although the molecular mechanisms for the transport of water-insoluble amphipathic fatty acids across cell membranes have been debated for many years, it is now believed that the dominant means for intestinal fatty acid uptake is via membrane-associated fatty acid-binding proteins, that is, fatty acid transporters on the apical membrane of enterocytes. RESULTS: These findings indicate that intestinal fatty acid absorption is a multistep process that is regulated by multiple genes at the enterocyte level, and intestinal fatty acid absorption efficiency could be determined by factors influencing intraluminal fatty acid molecules across the brush border membrane of enterocytes. To facilitate research on intestinal, hepatic and plasma triacylglycerol metabolism, it is imperative to establish standard protocols for precisely and accurately measuring the efficiency of intestinal fatty acid absorption in humans and animal models. In this review, we will discuss the chemical structure and nomenclature of fatty acids and summarize recent progress in investigating the molecular mechanisms underlying the intestinal absorption of fatty acids, with a particular emphasis on the physical chemistry of intestinal lipids and the molecular physiology of intestinal fatty acid transporters. CONCLUSIONS: A better understanding of the molecular mechanism of intestinal fatty acid absorption should lead to novel approaches to the treatment and the prevention of fatty acid-related metabolic diseases that are prevalent worldwide.


Assuntos
Ácidos Graxos/farmacocinética , Absorção Intestinal/fisiologia , Animais , Gorduras na Dieta/farmacocinética , Digestão/fisiologia , Proteínas de Transporte de Ácido Graxo/genética , Ácidos Graxos/química , Ácidos Graxos/classificação , Fezes/química , Humanos , Metabolismo dos Lipídeos/fisiologia , Lipoproteínas/metabolismo , Camundongos , Terminologia como Assunto
9.
Bioorg Med Chem Lett ; 19(4): 1177-82, 2009 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-19138846

RESUMO

Key binding interactions of the anthranilimide based glycogen phosphorylase a (GPa) inhibitor 2 from X-ray crystallography studies are described. This series of compounds bind to the AMP site of GP. Using the binding information the core and the phenyl urea moieties were optimized. This work culminated in the identification of compounds with single nanomolar potency as well as in vivo efficacy in a diabetic model.


Assuntos
Diabetes Mellitus Tipo 2/tratamento farmacológico , Glicogênio Fosforilase/antagonistas & inibidores , Hipoglicemiantes/síntese química , ortoaminobenzoatos/síntese química , ortoaminobenzoatos/farmacologia , Animais , Glicemia/análise , Técnicas de Química Combinatória , Cristalografia por Raios X , Modelos Animais de Doenças , Hipoglicemiantes/sangue , Hipoglicemiantes/química , Hipoglicemiantes/farmacologia , Camundongos , Conformação Molecular , Estrutura Molecular , Relação Estrutura-Atividade , Ureia/farmacologia , ortoaminobenzoatos/sangue , ortoaminobenzoatos/química
10.
Brain Res ; 1107(1): 82-96, 2006 Aug 30.
Artigo em Inglês | MEDLINE | ID: mdl-16859652

RESUMO

Large-scale expansion of neural stem and progenitor cells will be essential for clinically treating the large number of patients suffering from neurodegenerative disorders such as Parkinson's disease. Other applications of neural stem cell technology include further research in areas such as neural development or drug testing. Neural stem cells can be grown in vitro as tissue aggregates known as neurospheres, and in the current study, experiments were performed to determine the spatial arrangement and behavior of the cells within the neurosphere structure. A protocol utilizing sulfonated lipophilic fluorescent dyes was developed to effectively label populations of neural stem and progenitor cells without compromising cell density during culture. Cells retained the labels for at least 7 days. Using the labeling protocol, we discovered that the cells within the neurospheres were mobile and, moreover, the cells on the periphery of the neurospheres could migrate into the center of the neurospheres. Most important, the mixing time of two merging neurospheres was observed to be the same order of magnitude as the neural stem cell doubling time (approximately 20 h). This study is the first to show that the neurosphere system is dynamic, and these results will serve as a stepping stone to more in-depth studies of the neurosphere microenvironment.


Assuntos
Movimento Celular/fisiologia , Proliferação de Células , Neurônios/fisiologia , Células-Tronco/fisiologia , Engenharia Tecidual/métodos , Animais , Contagem de Células/métodos , Células Cultivadas , Embrião de Mamíferos , Citometria de Fluxo/métodos , Corantes Fluorescentes , Camundongos , Fatores de Tempo
11.
Bioorg Med Chem Lett ; 16(8): 2091-4, 2006 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-16460937

RESUMO

A set of novel heterocyclic pyrimidyl hydrazones has been synthesized as inhibitors of glycogen synthase kinase-3 (GSK-3) with the most active exhibiting low nanomolar activity. Quantum mechanical calculations indicate that of the conformational factors that could determine binding affinity, the planarity of the phenyl ring in relation to the central core and the conformation of the hydrazone chain may be the most influential.


Assuntos
Inibidores Enzimáticos/síntese química , Inibidores Enzimáticos/farmacologia , Quinase 3 da Glicogênio Sintase/antagonistas & inibidores , Compostos Heterocíclicos/síntese química , Compostos Heterocíclicos/farmacologia , Hidrazinas/síntese química , Hidrazinas/farmacologia , Concentração Inibidora 50 , Modelos Químicos , Estereoisomerismo
12.
J Med Chem ; 47(19): 4716-30, 2004 Sep 09.
Artigo em Inglês | MEDLINE | ID: mdl-15341487

RESUMO

Glycogen synthase kinase 3 regulates glycogen synthase, the rate-determining enzyme for glycogen synthesis. Liver and muscle glycogen synthesis is defective in type 2 diabetics, resulting in elevated plasma glucose levels. Inhibition of GSK-3 could potentially be an effective method to control plasma glucose levels in type 2 diabetics. Structure-activity studies on a N-phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine series have led to the identification of potent and selective compounds with good cellular efficacy. Molecular modeling studies have given insights into the mode of binding of these inhibitors. Since the initial leads were also potent inhibitors of CDK-2/CDK-4, an extensive SAR was performed at various positions of the pyrazolo[1,5-b]pyridazin core to afford potent GSK-3 inhibitors that were highly selective over CDK-2. In addition, these inhibitors also exhibited very good cell efficacy and functional response. A representative example was shown to have good oral exposure levels, extending their utility in an in vivo setting. These inhibitors provide a viable lead series in the discovery of new therapies for the treatment of type 2 diabetes.


Assuntos
Aminas/química , Inibidores Enzimáticos/química , Inibidores Enzimáticos/farmacologia , Quinase 3 da Glicogênio Sintase/antagonistas & inibidores , Piridazinas/química , Piridazinas/farmacologia , Animais , Sítios de Ligação , Linhagem Celular , Inibidores Enzimáticos/síntese química , Quinase 3 da Glicogênio Sintase/metabolismo , Humanos , Concentração Inibidora 50 , Modelos Moleculares , Estrutura Molecular , Estrutura Terciária de Proteína , Piridazinas/síntese química , Ratos , Relação Estrutura-Atividade
13.
Bioorg Med Chem Lett ; 14(9): 2121-5, 2004 May 03.
Artigo em Inglês | MEDLINE | ID: mdl-15080992

RESUMO

A series of [1-aryl-1H-pyrazolo[3,4-d]pyrimidin-4-yl]arylhydrazones were discovered as novel inhibitors glycogen synthase kinase-3 (GSK-3). Based on initial modeling a detailed SAR was constructed. Modification of the interior binding aryl ring (Ar(1)) determined this to be a tight binding region with little room for modification. As predicted from the model, a large variety of modifications could be incorporated into the hydrazone aryl ring. This work led to GSK-3 inhibitors in the low nano-molar range.


Assuntos
Inibidores Enzimáticos/farmacologia , Quinase 3 da Glicogênio Sintase/antagonistas & inibidores , Pirazóis/química , Pirimidinas/farmacologia , Inibidores Enzimáticos/química , Modelos Moleculares , Pirimidinas/química
14.
Bioorg Med Chem Lett ; 14(9): 2127-30, 2004 May 03.
Artigo em Inglês | MEDLINE | ID: mdl-15080993

RESUMO

A novel series of [1-(1H-benzimidazol-7-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl] arylhydrazones was synthesized and shown to potently inhibit glycogen synthase kinase-3 (GSK-3). In light of detailed structure-activity relationships and structural knowledge of the GSK-3 binding pocket, a benzimidazole substituent was incorporated onto the pyrazolopyrimidine core resulting in improved potency over previous analogs. More importantly, these derivatives show low nanomolar efficacy for stimulating glycogen synthesis in vitro and therefore may be useful in the treatment of type 2 diabetes mellitus.


Assuntos
Inibidores Enzimáticos/farmacologia , Quinase 3 da Glicogênio Sintase/antagonistas & inibidores , Hidrazonas/farmacologia , Animais , Linhagem Celular , Cães , Inibidores Enzimáticos/química , Hidrazonas/química , Modelos Moleculares
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...